Sanner achieves over EUR 85 million sales record

Germany-based Sanner, an international manufacturer of pharmaceutical primary packaging and medical technology products, has completed a successful business yr 2019, with a total turnover of only over EUR 85 million (approximately Rs 720 crore), company mentioned this in a printing statement.
Due to investments in new products and existing sites, Sanner is optimistic about the future despite the Corona crisis. With a grouping turnover of more than than EUR 85 million (approximately Rs 720 crore), Sanner has fix a new company tape. The development in Europe was stable; slight increases were achieved in China. The visitor recorded an above-average growth of 25% in the US and fifty-fifty more than 30% in India.
According to the company, the demand is particularly stiff for products from the "Engineered Product Solutions" segment. Sanner offers diagnostic solutions such as rapid tests and pulmonary applications such as inhalers and customized primary packaging.
"We will continue to expand our business in the coming years. This includes innovations in the existing Sanner product portfolio equally well equally investments in internal developments," says Johannis Willem van Vliet, managing director of the Sanner Group. "Nosotros are already successfully working on integrating electronics into injection molded parts. A further focus is on smart packaging and medical device development. We are thus expanding our competence and strengthening our value proffer – high volumes in plastics processing at the highest quality."
New products and market place segments
At the offset of this year, the company launched Sanner BioBase, the first effervescent tablet packaging fabricated of bio-based fabric. The tablet tube is recyclable and increases resource efficiency. Higher H20 barrier properties extend the tablets' shelf life, an essential argument for customers and consumers. In terms of handling, Sanner BioBase offers consumers a high-quality feel and appearance. The tube tin can be printed or provided with an IML label.
With its range of medical cannabis packaging, the company serves another market segment – and has already developed a starting time solution with the child-resistant tablet and capsule container TabTec CR. It features Sanner's patented 'Press and Flip' opening mechanism, making it hard for children to open, but easy for adults to open up and reclose. The integrated pouring opening allows individual capsules or tablets to exist removed easily and hygienically. Due to its slim shape, the container fits in any shirt or trouser pocket, while the innovative design stands out from other products at the betoken of sale.
Positive outlook despite Corona crunch
At Sanner, work continues despite the Covid-19 pandemic. The company has even increased its production capacity in Bensheim, Federal republic of germany, to meet the increased demand, such as for effervescent tablet packaging and medical devices such as inhalers or parts for rapid tests. Three new machines for the production of desiccant closures were already put into operation for this purpose. In Communist china, the plant was ramped up over again at the end of February after several weeks of closure and is now running at full speed, with the construction of the 2nd production constitute in physical planning.
Sanner is also continuing to invest in the Bensheim headquarters' infrastructure, for example, past implementing a new manufacturing execution system. "Nosotros look an increased demand for our products in Europe, the US and Asia – despite or fifty-fifty because of the Corona crisis," says van Vliet. "Accordingly, we are expecting sales to grow further this twelvemonth."
Source: https://packagingsouthasia.com/she-safety-health-and-environment/pharma-and-wellness/sanner-achieves-over-eur-85-million-sales-record/
0 Response to "Sanner achieves over EUR 85 million sales record"
Post a Comment